Exercise in a Pill May One Day Help with Obesity and Diabetes

With a series of new grants, Saint Louis University researchers are tackling the twin epidemics of diabetes and obesity by tapping into the potential of two nuclear receptors that control muscle metabolism. The scientists will optimize two promising drug compounds, moving a step closer toward capturing the benefits of exercise in pill form. Besides helping people suffering from obesity and diabetes, the research could help other groups of people including the aging, disabled and astronauts! The researchers have received $2.4 million from the U.S. Department of Defense and $1.74 million from the National Institutes of Health in a series of grants that will fund the study of two receptors linked to muscle metabolism: REV-ERB and ERR.

This series explores the latest science and technology news in the St. Louis area.

Exercise in a Pill May One Day Help with Obesity and Diabetes

Recent Segment | Innovations

The World's Largest 3D Printed Object for 777X Airplane at Boeing

The 777X wing trim and drill tool is now the world’s “largest solid 3-D printed item,” certified by Guinness World Records

Recent Segment | Innovations

Video Game Technology Helping Physical Therapy Patients & Athletes at Mizzou Lab

Mizzou researchers are using the depth camera associated with video game systems to help physical therapy patients and athletes.

Recent Segment | Innovations

New Software for Drug Companies to Make Drugs Cheaper, Faster and Better

New software will provide pharmaceutical companies the ability to develop drugs cheaper, faster and better by improving calculations of drug-target binding.

Recent Segment | Innovations

Scopio Finds Images on Social Media, Letting Users Get Paid for Their Photos

A company with roots in St.Louis is finding ways to sift through social media to find marketable photos. From there, they put brands and photographers together.

Episodes

There are 139 more episodes of Innovations.

Recent Segment | Innovations

New Method of Protection Against Pneumococcal Pneumonia

VaxNewMo has engineered E. coli to manufacture pneumococcal conjugate vaccines.

Register Now

Attend a live taping of this episode by filling out the form below.

Date: April 18, 2015 Time: 10:00am